LuanP. V., TienN. D., HaiN. M., TienN. D., & DuyenT. T. (2021). Real-world analysis of the effect of gefitinib as a first-line therapy in patients with advanced non-small cell lung cancer with EGFR mutations. Journal of 108 - Clinical Medicine and Phamarcy, 15(Tiếng Anh). Truy vấn từ https://tcydls108.benhvien108.vn/index.php/YDLS/article/view/733